Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREOB in early stage non-traumatic osteonecrosis of the femoral head
NCT01529008Phase 3Terminated
- Sponsor
- BioSenic
- Start
- Nov 2011
- Primary completion
- May 2017
- Modality
- Stem Cell Therapies
01
Overview
A Phase 3 trial of PREOB in osteonecrosis of the femoral head (ONFH), sponsored by BioSenic. Started Nov 2011; status: terminated.
02
Drugs
PREOB
03
Conditions
osteonecrosis of the femoral head (ONFH)
Beyond the preview
Go deeper on NCT01529008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01529008.